• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸机相关性肺炎复发的频率及预测因素:一项荟萃分析

Frequency and predictors of ventilator-associated pneumonia recurrence: a meta-analysis.

作者信息

Siempos Ilias I, Athanassa Zoe, Falagas Matthew E

机构信息

Alfa Institute of Biomedical Sciences, Athens, Greece.

出版信息

Shock. 2008 Nov;30(5):487-95. doi: 10.1097/SHK.0b013e31816f1f7c.

DOI:10.1097/SHK.0b013e31816f1f7c
PMID:18461027
Abstract

Large clinical series focusing on the risk factors associated with recurrence after the onset of an initial episode of ventilator-associated pneumonia (VAP) produced inconsistent results. A meta-analysis would be helpful to shed light on the issue. Our objective was to estimate the frequency of VAP recurrence and to identify risk factors associated with it. PubMed, Scopus, Current Contents, and references of retrieved articles were searched without language restrictions. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using both the Mantel-Haenszel fixed-effect and the DerSimonian-Laird random effects models. The overall frequency of VAP recurrence in 969 patients of the seven eligible reports was 26.8%. Among the 20 evaluated risk factors, only acute lung injury/acute respiratory distress syndrome (OR, 1.76; 95% CI, 1.12-2.75) and shock (OR, 1.55; 95% CI, 1.01-2.41) at the day of diagnosis of the first VAP episode were found to be associated with VAP recurrence. There was also evidence, albeit inconsistent, that severity of illness at intensive care unit admission was associated with VAP recurrence. Recurrence involves almost one in four cases of VAP and is associated with acute lung injury/acute respiratory distress syndrome and shock, but not with first-episode causative pathogens. Recognition of these predictors may permit the timely implementation of measures to prevent recurrence of VAP.

摘要

聚焦于呼吸机相关性肺炎(VAP)初发事件后复发相关危险因素的大型临床系列研究结果并不一致。荟萃分析有助于阐明这一问题。我们的目的是估计VAP复发的频率并确定与之相关的危险因素。对PubMed、Scopus、《现刊目次》以及检索文章的参考文献进行了检索,无语言限制。采用Mantel-Haenszel固定效应模型和DerSimonian-Laird随机效应模型计算合并比值比(OR)和95%置信区间(CI)。七项符合条件报告中的969例患者VAP复发的总体频率为26.8%。在评估的20个危险因素中,仅首次VAP发作诊断当天的急性肺损伤/急性呼吸窘迫综合征(OR,1.76;95%CI,1.12 - 2.75)和休克(OR,1.55;95%CI,1.01 - 2.41)与VAP复发相关。也有证据表明,尽管不一致,但重症监护病房入院时的疾病严重程度与VAP复发有关。复发几乎涉及四分之一的VAP病例,且与急性肺损伤/急性呼吸窘迫综合征和休克相关,但与首发事件的致病病原体无关。识别这些预测因素可能有助于及时采取措施预防VAP复发。

相似文献

1
Frequency and predictors of ventilator-associated pneumonia recurrence: a meta-analysis.呼吸机相关性肺炎复发的频率及预测因素:一项荟萃分析
Shock. 2008 Nov;30(5):487-95. doi: 10.1097/SHK.0b013e31816f1f7c.
2
Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.呼吸机相关性肺炎患者感染复发和死亡的早期预测因素
Crit Care Med. 2007 Jan;35(1):146-54. doi: 10.1097/01.CCM.0000249826.81273.E4.
3
Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis.成人呼吸机相关性肺炎患者死亡率的预测因素:一项荟萃分析。
Shock. 2010 Jun;33(6):590-601. doi: 10.1097/SHK.0b013e3181cc0418.
4
Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.非创伤性重症监护病房患者的迟发性呼吸机相关性肺炎
Anesth Analg. 2009 Nov;109(5):1584-90. doi: 10.1213/ANE.0b013e3181b6e9b6. Epub 2009 Aug 27.
5
Risk factors for relapse of ventilator-associated pneumonia in trauma patients.创伤患者呼吸机相关性肺炎复发的危险因素
J Trauma. 2009 Jul;67(1):91-5; discussion 95-6. doi: 10.1097/TA.0b013e3181a8b2b2.
6
Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?对于重症外科患者,呼吸机相关性肺炎抗生素治疗的降阶梯疗法是否会影响复发性肺炎的可能性或死亡率?
J Trauma. 2009 May;66(5):1343-8. doi: 10.1097/TA.0b013e31819dca4e.
7
Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials.益生菌给药对呼吸机相关性肺炎发生率的影响:一项随机对照试验的荟萃分析。
Crit Care Med. 2010 Mar;38(3):954-62. doi: 10.1097/CCM.0b013e3181c8fe4b.
8
Risk factors associated with development of ventilator associated pneumonia.与呼吸机相关性肺炎发生相关的危险因素。
J Coll Physicians Surg Pak. 2005 Feb;15(2):92-5.
9
Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis.局部应用氯己定预防呼吸机相关性肺炎:一项荟萃分析。
Crit Care Med. 2007 Feb;35(2):595-602. doi: 10.1097/01.CCM.0000253395.70708.AC.
10
Risk factors and outcomes for ventilator-associated pneumonia in neonatal intensive care unit patients.新生儿重症监护病房患者呼吸机相关性肺炎的危险因素及预后
J Perinat Med. 2007;35(4):334-8. doi: 10.1515/JPM.2007.065.

引用本文的文献

1
A Predominant Cause of Recurrence of Ventilator-Associated Pneumonia in Patients with COVID-19 Are Relapses.新冠病毒肺炎患者呼吸机相关性肺炎复发的一个主要原因是病情复发。
J Clin Med. 2023 Sep 7;12(18):5821. doi: 10.3390/jcm12185821.
2
Association between combination antibiotic therapy as opposed as monotherapy and outcomes of ICU patients with Pseudomonas aeruginosa ventilator-associated pneumonia: an ancillary study of the iDIAPASON trial.与单药治疗相比,联合抗生素治疗与 ICU 铜绿假单胞菌呼吸机相关性肺炎患者结局的相关性:iDIAPASON 试验的辅助研究。
Crit Care. 2023 May 30;27(1):211. doi: 10.1186/s13054-023-04457-y.
3
Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial.
减少呼吸机相关性肺炎的抗生素治疗时间(REGARD-VAP):一项随机临床试验的试验方案。
BMJ Open. 2021 May 13;11(5):e050105. doi: 10.1136/bmjopen-2021-050105.
4
Clinical Implications of Microbiologic Treatment Failure in the Setting of Clinical Cure of Bacterial Pneumonia.临床治愈细菌性肺炎时微生物治疗失败的临床意义。
Clin Infect Dis. 2020 Dec 15;71(12):3033-3041. doi: 10.1093/cid/ciz1187.
5
Clinical epidemiology and outcomes of ventilator-associated pneumonia in critically ill adult patients: protocol for a large-scale systematic review and planned meta-analysis.重症成人患者呼吸机相关性肺炎的临床流行病学和结局:一项大规模系统评价和计划荟萃分析的方案。
Syst Rev. 2019 Jul 20;8(1):180. doi: 10.1186/s13643-019-1080-y.
6
New Delhi metallo-β-lactamase-producing isolates among late-onset VAP patients: multidrug-resistant pathogen and poor outcome.晚发性呼吸机相关性肺炎患者中产生新德里金属β-内酰胺酶的分离株:多重耐药病原体与不良预后。
Infect Drug Resist. 2019 Feb 11;12:373-384. doi: 10.2147/IDR.S186924. eCollection 2019.
7
Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol.多中心随机对照试验,旨在研究直接从呼吸道、尿液或血液样本的细菌细胞沉淀中进行快速诊断βLACTA 测试,对脓毒症重症监护病房患者碳青霉烯类药物早期降阶梯治疗的有效性:BLUE-CarbA 方案。
BMJ Open. 2019 Feb 19;9(2):e024561. doi: 10.1136/bmjopen-2018-024561.
8
Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.抗生素使用时长对铜绿假单胞菌呼吸机相关性肺炎患者临床事件的影响:一项随机对照研究的研究方案
Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3.